Chat with us, powered by LiveChat

Loading...

Biopharmaceuticals Manufacturing Consumables Testing Market Report

RA02116

Biopharmaceuticals Manufacturing Consumables Testing Market, by Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial & Multi Compendial Laboratory Testing), Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA02116

Pages: 400

Feb 2023

The global biopharmaceuticals manufacturing consumables testing market is estimated to surpass $891.2 million by 2027, exhibiting a CAGR of 12.1% from 2020 to 2027.

The report provides all-inclusive analysis of global biopharmaceuticals manufacturing consumables testing market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.

The report emphasizes current market scenario and future trends of the global biopharmaceuticals manufacturing consumables testing market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global biopharmaceuticals manufacturing consumables testing market.

In addition, the report provides market size and forecast scrutinizing global biopharmaceuticals manufacturing consumables testing market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global biopharmaceuticals manufacturing consumables testing market. In the report, the global biopharmaceuticals manufacturing consumables testing market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover biopharmaceuticals manufacturing consumables testing market landscape in respective regions.

Furthermore, competitive scenario of the global biopharmaceuticals manufacturing consumables testing market is covered in the report. Major players functioning in the global biopharmaceuticals manufacturing consumables testing market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global biopharmaceuticals manufacturing consumables testing market, and others.

Research Methodology

Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.

This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global biopharmaceuticals manufacturing consumables testing market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.

KEY MARKET BENEFITS

  • This report is a compilation of detailed study, information, valid inputs from industry experts & industry participants across the value chain, and quantitative & qualitative assessment by analysts of the industry.
  • The report provides a comprehensive analysis along with the current trends of market during the forecast period from 2019 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global biopharmaceuticals manufacturing consumables testing market growth.
  • The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies.
  • The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the biopharmaceuticals manufacturing consumables testing market.
  • The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global biopharmaceuticals manufacturing consumables testing market.

KEY MARKET SEGMENTS

The market has been studied based on the following segments:

  • Service: Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial & Multi Compendial Laboratory Testing
  • Type: Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods

Region:

The global biopharmaceuticals manufacturing consumables testing market is divided into North America, Europe, Asia Pacific, and LAMEA.

The above-mentioned regions are further dived in countries as follows:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of LAMEA

 

KEY MARKET PLAYERS

The report covers the major players operating in the global biopharmaceuticals manufacturing consumables testing market that focus on advancements & innovations and geographical expansion of product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include Gibraltar Laboratories, Gibraltar Laboratories, Avomeen Analytical Services, Agilent Technologies, …., and others.

The report summarizes various aspects of all these key players that include as follows:

    1. Alcami Corporation

    2. Merck KGaA

    3. Eurofins Scientific

    4. Agilent Technologies

    5. Charles River

    6. Catalent, Inc.

    7. Avomeen Analytical Services

    8. BioSpectra

    9. and Pace Analytical Services, LLC

    10. Gibraltar Laboratories

    11. Pacific BioLabs

  • 1. RESEARCH METHODOLOGY

    • 1.1. Desk Research

    • 1.2. Real time insights and validation

    • 1.3. Forecast model

    • 1.4. Assumptions and forecast parameters

    • 1.5. Market size estimation

      • 1.5.1. Top-down approach

      • 1.5.2. Bottom-up approach

  • 2. REPORT SCOPE

    • 2.1. Market definition

    • 2.2. Key objectives of the study

    • 2.3. Report overview

    • 2.4. Market segmentation

    • 2.5. Overview of the impact of COVID-19 on Global Biopharmaceuticals Manufacturing Consumables Testing Market

  • 3. EXECUTIVE SUMMARY

  • 4. MARKET OVERVIEW

    • 4.1. Introduction

    • 4.2. Growth impact forces

      • 4.2.1. Drivers

      • 4.2.2. Restraints

      • 4.2.3. Opportunities

    • 4.3. Market value chain analysis

      • 4.3.1. List of raw material suppliers

      • 4.3.2. List of manufacturers

      • 4.3.3. List of distributors

    • 4.4. Innovation & sustainability matrices

      • 4.4.1. Technology matrix

      • 4.4.2. Regulatory matrix

    • 4.5. Porter’s five forces analysis

      • 4.5.1. Bargaining power of suppliers

      • 4.5.2. Bargaining power of consumers

      • 4.5.3. Threat of substitutes

      • 4.5.4. Threat of new entrants

      • 4.5.5. Competitive rivalry intensity

    • 4.6. PESTLE analysis

      • 4.6.1. Political

      • 4.6.2. Economical

      • 4.6.3. Social

      • 4.6.4. Technological

      • 4.6.5. Environmental

    • 4.7. Impact of COVID-19 on Biopharmaceuticals Manufacturing Consumables Testing Market

      • 4.7.1. Pre-covid market scenario

      • 4.7.2. Post-covid market scenario

  • 5. Biopharmaceuticals Manufacturing Consumables Testing Market, By Application

    • 5.1. Overview

    • 5.2 Laboratory Testing

      • 5.2.1 Definition, key trends, growth factors, and opportunities

      • 5.2.2 Market size analysis, by region, 2020-2027

      • 5.2.3 Market share analysis, by country, 2020-2027

    • 5.3 Custom Testing / Customer Proprietary Testing

      • 5.3.1 Definition, key trends, growth factors, and opportunities

      • 5.3.2 Market size analysis, by region, 2020-2027

      • 5.3.3 Market share analysis, by country, 2020-2027

    • 5.4 Compendial & Multi Compendial Laboratory Testing

      • 5.4.1 Definition, key trends, growth factors, and opportunities

      • 5.4.2 Market size analysis, by region, 2020-2027

      • 5.4.3 Market share analysis, by country, 2020-2027

    • 5.5 Research Dive Exclusive Insights

      • 5.5.1 Market attractiveness

      • 5.5.2 Competition heatmap

  • 6. Biopharmaceuticals Manufacturing Consumables Testing Market, By Distribution Channel

    • 6.1. Overview

    • 6.2 Formulation Excipients

      • 6.2.1 Definition, key trends, growth factors, and opportunities

      • 6.2.2 Market size analysis, by region, 2020-2027

      • 6.2.3 Market share analysis, by country, 2020-2027

    • 6.3 Active Pharmaceutical Ingredients (API)

      • 6.3.1 Definition, key trends, growth factors, and opportunities

      • 6.3.2 Market size analysis, by region, 2020-2027

      • 6.3.3 Market share analysis, by country, 2020-2027

    • 6.4 Compendial Methods

      • 6.4.1 Definition, key trends, growth factors, and opportunities

      • 6.4.2 Market size analysis, by region, 2020-2027

      • 6.4.3 Market share analysis, by country, 2020-2027

    • 6.5 Research Dive Exclusive Insights

      • 6.5.1 Market attractiveness

      • 6.5.2 Competition heatmap

  • 7. Biopharmaceuticals Manufacturing Consumables Testing Market, By Region

    • 7.1 North America

      • 7.1.1 U.S

        • 7.1.1.1 Market size analysis, By Application, 2020-2027

        • 7.1.1.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.1.2 Canada

        • 7.1.2.1 Market size analysis, By Application, 2020-2027

        • 7.1.2.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.1.3 Mexico

        • 7.1.3.1 Market size analysis, By Application, 2020-2027

        • 7.1.3.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.1.4 Research Dive Exclusive Insights

        • 7.1.4.1 Market attractiveness

        • 7.1.4.2 Competition heatmap

    • 7.2 Europe

      • 7.2.1 Germany

        • 7.2.1.1 Market size analysis, By Application, 2020-2027

        • 7.2.1.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.2.2 UK

        • 7.2.2.1 Market size analysis, By Application, 2020-2027

        • 7.2.2.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.2.3 France

        • 7.2.3.1 Market size analysis, By Application, 2020-2027

        • 7.2.3.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.2.4 Spain

        • 7.2.4.1 Market size analysis, By Application, 2020-2027

        • 7.2.4.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.2.5 Italy

        • 7.2.5.1 Market size analysis, By Application, 2020-2027

        • 7.2.5.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.2.6 Rest of Europe

        • 7.2.6.1 Market size analysis, By Application, 2020-2027

        • 7.2.6.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.2.7 Research Dive Exclusive Insights

        • 7.2.7.1 Market attractiveness

        • 7.2.7.2 Competition heatmap

    • 7.3 Asia-Pacific

      • 7.3.1 China

        • 7.3.1.1 Market size analysis, By Application, 2020-2027

        • 7.3.1.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.3.2 Japan

        • 7.3.2.1 Market size analysis, By Application, 2020-2027

        • 7.3.2.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.3.3 India

        • 7.3.3.1 Market size analysis, By Application, 2020-2027

        • 7.3.3.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.3.4 Australia

        • 7.3.4.1 Market size analysis, By Application, 2020-2027

        • 7.3.4.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.3.5 South Korea

        • 7.3.5.1 Market size analysis, By Application, 2020-2027

        • 7.3.5.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.3.6 Rest of Asia-Pacific

        • 7.3.6.1 Market size analysis, By Application, 2020-2027

        • 7.3.6.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.3.7 Research Dive Exclusive Insights

        • 7.3.7.1 Market attractiveness

        • 7.3.7.2 Competition heatmap

    • 7.4 LAMEA

      • 7.4.1 Brazil

        • 7.4.1.1 Market size analysis, By Application, 2020-2027

        • 7.4.1.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.4.2 Saudi Arabia

        • 7.4.2.1 Market size analysis, By Application, 2020-2027

        • 7.4.2.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.4.3 UAE

        • 7.4.3.1 Market size analysis, By Application, 2020-2027

        • 7.4.3.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.4.4 South Africa

        • 7.4.4.1 Market size analysis, By Application, 2020-2027

        • 7.4.4.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.4.5 Rest of LAMEA

        • 7.4.5.1 Market size analysis, By Application, 2020-2027

        • 7.4.5.2 Market size analysis, By Distribution Channel, 2020-2027

      • 7.4.6 Research Dive Exclusive Insights

        • 7.4.6.1 Market attractiveness

        • 7.4.6.2 Competition heatmap

  • 8. Competitive Landscape

    • 8.1 Top winning strategies, 2020-2027

      • 8.1.1 By strategy

      • 8.1.2 By year

    • 8.2 Strategic overview

    • 8.3 Market share analysis, 2020-2027

  • 9. Company Profiles

    • 9.1 Alcami Corporation

      • 9.1.1 Overview

      • 9.1.2 Business segments

      • 9.1.3 Product portfolio

      • 9.1.4 Financial performance

      • 9.1.5 Recent developments

      • 9.1.6 SWOT analysis

    • 9.2 Merck KGaA

      • 9.2.1 Overview

      • 9.2.2 Business segments

      • 9.2.3 Product portfolio

      • 9.2.4 Financial performance

      • 9.2.5 Recent developments

      • 9.2.6 SWOT analysis

    • 9.3 Eurofins Scientific

      • 9.3.1 Overview

      • 9.3.2 Business segments

      • 9.3.3 Product portfolio

      • 9.3.4 Financial performance

      • 9.3.5 Recent developments

      • 9.3.6 SWOT analysis

    • 9.4 Agilent Technologies

      • 9.4.1 Overview

      • 9.4.2 Business segments

      • 9.4.3 Product portfolio

      • 9.4.4 Financial performance

      • 9.4.5 Recent developments

      • 9.4.6 SWOT analysis

    • 9.5 Charles River

      • 9.5.1 Overview

      • 9.5.2 Business segments

      • 9.5.3 Product portfolio

      • 9.5.4 Financial performance

      • 9.5.5 Recent developments

      • 9.5.6 SWOT analysis

    • 9.6 Catalent, Inc.

      • 9.6.1 Overview

      • 9.6.2 Business segments

      • 9.6.3 Product portfolio

      • 9.6.4 Financial performance

      • 9.6.5 Recent developments

      • 9.6.6 SWOT analysis

    • 9.7 Avomeen Analytical Services

      • 9.7.1 Overview

      • 9.7.2 Business segments

      • 9.7.3 Product portfolio

      • 9.7.4 Financial performance

      • 9.7.5 Recent developments

      • 9.7.6 SWOT analysis

    • 9.8 BioSpectra

      • 9.8.1 Overview

      • 9.8.2 Business segments

      • 9.8.3 Product portfolio

      • 9.8.4 Financial performance

      • 9.8.5 Recent developments

      • 9.8.6 SWOT analysis

    • 9.9 and Pace Analytical Services, LLC

      • 9.9.1 Overview

      • 9.9.2 Business segments

      • 9.9.3 Product portfolio

      • 9.9.4 Financial performance

      • 9.9.5 Recent developments

      • 9.9.6 SWOT analysis

    • 9.10 Gibraltar Laboratories

      • 9.10.1 Overview

      • 9.10.2 Business segments

      • 9.10.3 Product portfolio

      • 9.10.4 Financial performance

      • 9.10.5 Recent developments

      • 9.10.6 SWOT analysis

    • 9.11 Pacific BioLabs

      • 9.11.1 Overview

      • 9.11.2 Business segments

      • 9.11.3 Product portfolio

      • 9.11.4 Financial performance

      • 9.11.5 Recent developments

      • 9.11.6 SWOT analysis

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed